Largest biotech companies by cash on hand

Cash and cash equivalents at the end of the latest fiscal year. Short-term investments are not counted.

Amgen leads the 24 biotech companies ranked by cash on hand, at ZAR 158.3B, ahead of BioNTech (ZAR 147.7B) and Gilead Sciences (ZAR 131.2B). Figures as of 19 Nov 2026, 03:57 UTC, from Yahoo Finance quotes.

Key facts

Companies ranked
24
First
AmgenZAR 158.3B
Median
ZAR 7.5B
Combined market value
ZAR 14.5T
Countries
5

Market values as of .

All countries
All sectors
Biotech
ZAR
Clear filters
Largest biotech companies by cash on hand
#CompanyCash on hand ↓Market capPriceToday1 yearPrice, 30 daysCountry
1AmgenAMGN · Health CareZAR 158.3BZAR 4.16TZAR 7,697.07 3.07% down 34% up United States
2BioNTechBNTX · Health CareZAR 147.7BZAR 357.9BZAR 1,443.73 1.89% down 16% down Germany
3Gilead SciencesGILD · Health CareZAR 131.2BZAR 3.63TZAR 2,930.12 0.75% down 33% up United States
4argenxARGX · Health CareZAR 60.5BZAR 1.03TZAR 16,321.30 0.66% down 4% up Belgium
5BiogenBIIB · Health CareZAR 52.2BZAR 644.4BZAR 4,359.46 0.25% up 49% up United States
6ModernaMRNA · Health CareZAR 45BZAR 1.38TZAR 3,412.34 4.84% down 755% up United States
7ImmunovantIMVT · Health CareZAR 15.6BZAR 119BZAR 575.17 0.12% down 43% up United States
8QiagenQGEN · Health CareZAR 14.5BZAR 177.5BZAR 859.37 0.38% down 12% up Netherlands
9Neurocrine BiosciencesNBIX · Health CareZAR 12.4BZAR 285.8BZAR 2,824.00 1.84% down 20% up United States
10RepligenRGEN · Health CareZAR 9.8BZAR 191.4BZAR 2,994.10 6.47% up 5% up United States
11Krystal BiotechKRYS · Health CareZAR 8.6BZAR 162BZAR 5,468.01 5.62% up 46% up United States
12ExelixisEXEL · Health CareZAR 8.4BZAR 288.9BZAR 1,184.15 0.31% down 63% up United States
13Revolution MedicinesRVMD · Health CareZAR 6.7BZAR 599.4BZAR 2,771.28 1.76% down 131% up United States
14Kymera TherapeuticsKYMR · Health CareZAR 6.2BZAR 179.3BZAR 2,100.40 0.32% down 87% up United States
15CRISPR TherapeuticsCRSP · Health CareZAR 6BZAR 67.6BZAR 696.90 0.10% up 21% down Switzerland
16Scholar Rock HoldingSRRK · Health CareZAR 5.6BZAR 101.5BZAR 832.32 6.48% up 14% up United States
17Bio-TechneTECH · Health CareZAR 4.6BZAR 198.2BZAR 1,261.49 0.17% up 26% up United States
18Kodiak SciencesKOD · Health CareZAR 3.6BZAR 110.9BZAR 1,696.03 1.04% up 396% up United States
19Twist BioscienceTWST · Health CareZAR 3.2BZAR 137.6BZAR 2,017.51 3.88% up 340% up United States
20VaxcytePCVX · Health CareZAR 3BZAR 160.6BZAR 1,014.74 1.48% down 22% up United States
21Halozyme TherapeuticsHALO · Health CareZAR 2.3BZAR 189.4BZAR 1,661.17 0.18% down 37% up United States
22ImmunityBioIBRX · Health CareZAR 1.5BZAR 123.6BZAR 116.18 7.03% up 193% up United States
23Adaptive BiotechnologiesADPT · Health CareZAR 1.2BZAR 79.9BZAR 493.50 0.11% down 88% up United States
24CG OncologyCGON · Health CareZAR 563.4MZAR 123.9BZAR 1,387.20 1.34% up 85% up United States

Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.

Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Cash on hand is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 17.3400 ZAR).

Questions and answers

Which biotech companies rank first by cash on hand?

Amgen (ZAR 158.3B), BioNTech (ZAR 147.7B) and Gilead Sciences (ZAR 131.2B) are the top three of the 24 biotech companies ranked by cash on hand as of 19 Nov 2026, 03:57 UTC.

How many biotech companies are in this ranking?

24 are ranked by cash on hand.

What are these biotech companies worth together?

The 24 biotech companies ranked by cash on hand have a combined market value of ZAR 14.5T as of 19 Nov 2026, 03:57 UTC.

What does ranking by cash on hand measure?

Cash and cash equivalents at the end of the latest fiscal year. Short-term investments are not counted.

Cite this page

Funkfolio, “Largest biotech companies by cash on hand”, data as of 19 November 2026. https://funkfolio.com/companies/category/biotech?by=cash-on-hand

Underlying data: Yahoo Finance; SEC EDGAR.